Roivant Sciences
Posted on: October 31, 2019
By: Kim Berlowitz
With: Comments Off on Roivant Sciences
Exclusive financial advisor to Roivant in its sale of select assets, access to Health technology, and 10% equity to Dainippon Sumitomo Pharma